BRNS vs CME · $38.2M cap vs P/E 22, rev $3.59B
Barinthus Biotherapeutics plc (BRNS) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
BRNS currently screens at market cap $38.2M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the BRNS and CME stock pages for the full models.
Not investment advice.